Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021)
Minerva Neurosciences (NERV) posted Other Non-Current Assets of $14808.0 for Q2 2021, little changed on a QoQ basis from $14808.0 in Q1 2021, and little changed year-over-year from $14808.0 in Q2 2020.
Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021) Analysis & Trends
Minerva Neurosciences' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $14808.0 for Q2 2021.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $14808.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $14808.0 (changed 0.0% YoY) and the FY2020 annual result came in at $14808.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $14808.0 for Q2 2021 at Minerva Neurosciences, roughly flat from $14808.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $14808.0 in Q4 2017 and bottomed at $14808.0 in Q4 2017.
- A 5-year average of $14808.0 and a median of $14808.0 in 2017 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
- Minerva Neurosciences' Other Non-Current Assets stood at $14808.0 in 2017, then changed by 0.0% to $14808.0 in 2018, then changed by 0.0% to $14808.0 in 2019, then changed by 0.0% to $14808.0 in 2020, then changed by 0.0% to $14808.0 in 2021.
- Business Quant data shows NERV's Other Non-Current Assets at $14808.0 in Q2 2021, $14808.0 in Q1 2021, and $14808.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 14,808.00 |
| Mar 31, 2021 | 14,808.00 |
| Dec 31, 2020 | 14,808.00 |
| Sep 30, 2020 | 14,808.00 |
| Jun 30, 2020 | 14,808.00 |
| Mar 31, 2020 | 14,808.00 |
| Dec 31, 2019 | 14,808.00 |
| Sep 30, 2019 | 14,808.00 |
| Jun 30, 2019 | 14,808.00 |
| Mar 31, 2019 | 14,808.00 |
| Dec 31, 2018 | 14,808.00 |
| Sep 30, 2018 | 14,808.00 |
| Jun 30, 2018 | 14,808.00 |
| Mar 31, 2018 | 14,808.00 |
| Dec 31, 2017 | 14,808.00 |
| Jun 30, 2014 | 3.11 Mn |
| Dec 31, 2013 | 433,998.00 |